AGA proposes first pharmacologic treatment plan for patients with IBS-C, IBS-D

The AGA has issued clinical guidelines that outline a pharmacologic treatment plan for patients with irritable bowel syndrome and its subtypes, IBS-constipation and IBS-diarrhea, which were published in Gastroenterology.For the first time, these guidelines offer recommendations on when to use newly introduced drugs, when to rely on FDA-approved drugs and when over-the-counter drugs may be suitable. The guidelines also provide a framework for tailoring treatment approaches to patients’ specific symptoms.“We have so many treatment options, we can now take a targeted treatmentRead More

Generated by Feedzy